GENE ONLINE|News &
Opinion
Blog

2022-11-15| In-DepthSpecial

Walmart To Settle Opioid Lawsuits with $3.1 Billion, U.S. Government Mulls OTC Naloxone

by Reed Slater
Share To
In an effort to close the door on its thousands of opioid lawsuits, Walmart announced a sweeping nationwide settlement framework, agreeing to pay $3.1 billion to resolve all lawsuits by state, local, and tribal governments. The retail behemoth said the payments would significantly aid the fight against opioids. On the same day, the FDA and the Department of Health and Human Resources (HHS) published a proposal to transition naloxone, a treatment used to reverse the effects of opioid overdose, to over-the-counter medication.

It's free! Log in now to read

LATEST
NDA for Biogen-Sage’s Zuranolone Accepted by FDA, Marking Another Step Forward in Depression Drug Development
2023-02-07
BMS Returns $475 Million Cancer Asset To Dragonfly Therapeutics
2023-02-07
FDA Expands Approval For Takeda’s Takhzyro To Prevent Hereditary Angioedema Attacks
2023-02-06
Abbott’s New Technologies for Arrhythmia Treatment Secure FDA and European Approval
2023-02-04
First Human Trial for Marburg Virus Vaccine Reports Success
2023-02-03
Karuna Licenses Goldfinch’s Mood Disorder Candidates For Potential $535 Million
2023-02-03
Novel Bioengineered Wearable Edgeless Skin Brings Hope to Revolutionize Plastic and Reconstructive Surgery
2023-02-03
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!